The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
基本信息
- 批准号:8348915
- 负责人:
- 金额:$ 138.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseActivinsAdenocarcinomaAdultAnteriorAntibodiesAppearanceBindingBiological ProcessBreast CarcinomaBreast HyperplasiaCFC1 geneCellsCervix carcinomaColonColon CarcinomaColonic AdenomaDisease ProgressionDuctal Epithelial CellEGF geneEmbryoEmbryonic DevelopmentEndodermEpithelialEpithelial CellsEyeFemaleGene FamilyGenesGenetic TranscriptionGlypicanHeparitin SulfateHistologicHumanHuman MilkIntestinal MetaplasiaIntraductal HyperplasiaLactationLeftLesionLinkLuciferasesMAP Kinase GeneMalignant neoplasm of lungMalignant neoplasm of pancreasMammary glandMesenchymalMesodermMorphogenesisMouse Mammary Tumor VirusMultigene FamilyMusNeoplasm MetastasisNodalNoninfiltrating Intraductal CarcinomaOvarian CarcinomaPancreatic carcinomaPapillaryPathogenesisPhase I Clinical TrialsPhosphorylationPlasmaPregnancyPremalignantProteinsProteoglycanRecombinantsRegulationReporterResearchRoleSRC geneSignal PathwayStomachTissuesToxin ConjugatesTransgenesVimentinXenopusZebrafishadult stem cellangiogenesisbeta catenincell motilitycompetence factordesignembryonic stem cellepithelial to mesenchymal transitionglycogen synthase kinase 3 betahuman NTN1 proteinlung Carcinomamalignant breast neoplasmmalignant stomach neoplasmneoplastic cellnetrin-1novel markeroverexpressionprogramspromoterreceptorrelating to nervous system
项目摘要
The EGF-CFC gene family encodes a group of structurally related proteins that serve as important competence factors during early embryogenesis in Xenopus, zebrafish, mice and humans. This multigene family consists of Xenopus FRL-1, zebrafish one-eyed-pinhead (oep ), mouse cripto (Cr-1) and cryptic and human cripto (CR-1) and criptin. FRL-1, oep and mouse cripto are essential for the formation of mesoderm and endoderm and for correct establishment of the embryonic anterior/posterior axis. In addition, oep and cryptic are important for the establishment of left-right asymmetry. In the mouse cryptic is not expressed in adult tissues whereas Cr-1 is expressed at a low level in several different tissues including the mammary gland. In the mammary gland, expression of Cr-1 in the ductal epithelial cells increases during pregnancy and lactation and immunoreactive and biologically active Cr-1 protein can be detected in human milk. Overexpression of a human CR-1 transgene in the mouse mammary gland using an MMTV orWAP promoter results in the appearance of ductal hyperplasias in the mammary gland and papillary amd histologically mixed subtypes of adenocarcinomas in multiparous female mice. Recombinant mouse or human cripto can enhance cell motility and branching morphogenesis in mouse mammary epithelial cells and in some human tumor cells. These effects are accompanied by an epithelial-mesenchymal transition which is associated with a decrease in beta-catenin adherens function and an increase in vimentin expression. Expression of CR-1 is increased several-fold in human colon, gastric, pancreatic, cervical, ovarian and lung carcinomas and in a variety of different types of mouse and human breast carcinomas. More importantly, this increase in cripto-1 expression can first be detected in premalignant lesions in some of these tissues such as in the breast ( hyperplasias and DCIS ), colon ( adenomas ) and stomach ( intestinal metaplasias ). We have recently identied the Activin ALK4 type 1 receptor as a co-receptor for CR-1 which presents Nodal to ALK4 and thereby can stimulate Smad-2 phosphorylation and transcription through an SBE-luciferase reporter construct.In addition, CR-1 can function through a Nodal and ALK4-independent signaling pathway and activate MAPK, PI-3 kinase and Akt by binding to the GPI-linked heparan sulphate-containing proteoglycan, glypican-1 which can then activate c-src. Activation of MAPK, PI-3 kinase, GSK-3beta and Akt in mammary epithelial cells by CR-1 are required for the ability of CR-1 to stimulate epithelial to mesenchymal transition, cell migration and cell invasion which is invovled in metastasis and angiogenesis. The invasive effects of CR-1 can be antagonized by the neural guidance protein Netrin-1 through the UNC5b receptor in mammary epithelial cells. CR-1 is also invovled in maintaing embryonic stem cell pluripotentiality and may perform a similar function in adult stem cells in the mammary gland and colon. CR-1 can be found at significant levels in the plasma of breast and colon cancer paptients and may therefore represent a novel marker to detect the onset or progression of these diseases.
EGF-CFC基因家族编码一组结构相关蛋白,在爪蟾、斑马鱼、小鼠和人类的早期胚胎发生过程中起着重要的能力因子作用。该多基因家族包括爪蟾FRL-1、斑马鱼单眼针头(oep)、小鼠密码子(Cr-1)以及隐密码子和人密码子(Cr-1)和密码子。FRL-1、oep和小鼠cripto对于中胚层和内胚层的形成以及胚胎前/后轴的正确建立至关重要。此外,oep和cryptic对于左右不对称的建立也很重要。在小鼠中,隐型在成人组织中不表达,而Cr-1在包括乳腺在内的几种不同组织中表达水平较低。在乳腺中,妊娠和哺乳期导管上皮细胞中Cr-1的表达增加,在人乳中可以检测到免疫反应性和生物活性的Cr-1蛋白。使用MMTV或wap启动子在小鼠乳腺中过度表达人CR-1转基因可导致多胎雌性小鼠乳腺导管增生、乳头状腺癌和组织学混合亚型腺癌的出现。重组小鼠或人密码子可增强小鼠乳腺上皮细胞和部分人肿瘤细胞的细胞运动性和分支形态发生。这些作用伴随着上皮-间质转化,这与β -连环蛋白粘附功能的降低和vimentin表达的增加有关。CR-1在人类结肠癌、胃癌、胰腺癌、宫颈癌、卵巢癌和肺癌以及各种不同类型的小鼠和人类乳腺癌中的表达增加了数倍。更重要的是,这种cripto-1表达的增加可以首先在这些组织中的一些癌前病变中检测到,例如乳腺(增生和DCIS)、结肠(腺瘤)和胃(肠化生)。我们最近发现激活素ALK4型1受体是CR-1的共受体,它与ALK4呈节点关系,因此可以通过sbe -荧光素酶报告基因结构刺激Smad-2磷酸化和转录。此外,CR-1可以通过Nodal和alk4独立的信号通路发挥作用,并通过结合gpi连接的含硫酸肝素的蛋白聚糖glypican-1激活MAPK, PI-3激酶和Akt,然后激活c-src。CR-1激活乳腺上皮细胞的MAPK、PI-3激酶、gsk -3 β和Akt,是CR-1刺激上皮向间质转化、细胞迁移和细胞侵袭参与转移和血管生成的必要条件。在乳腺上皮细胞中,神经引导蛋白Netrin-1可通过UNC5b受体拮抗CR-1的侵袭作用。CR-1也参与维持胚胎干细胞的多能性,并可能在乳腺和结肠的成体干细胞中发挥类似的功能。CR-1在乳腺癌和结肠癌患者的血浆中含量显著,因此可能是检测这些疾病发生或进展的新标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID SALOMON其他文献
DAVID SALOMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID SALOMON', 18)}}的其他基金
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
7732932 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
7292123 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
6433130 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
7965131 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
THE ROLE OF EGF-RELATED PEPTIDES IN THE PATHOGENESIS OF BREAST AND COLON CANCER
EGF 相关肽在乳腺癌和结肠癌发病机制中的作用
- 批准号:
6289225 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
7338127 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
8552609 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Col
Cripto 在乳腺和结肠发病机制中的作用
- 批准号:
6762087 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
7592590 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Cripto 在乳腺癌和结肠癌发病机制中的作用
- 批准号:
8157216 - 财政年份:
- 资助金额:
$ 138.08万 - 项目类别:
相似海外基金
Effects of activins and activin-binding proteins on fetal lung development
激活素和激活素结合蛋白对胎儿肺发育的影响
- 批准号:
23K08875 - 财政年份:2023
- 资助金额:
$ 138.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : 1078907 - 财政年份:2015
- 资助金额:
$ 138.08万 - 项目类别:
Project Grants
Targeting Activins to treat cachexia
靶向激活素治疗恶病质
- 批准号:
nhmrc : GNT1078907 - 财政年份:2015
- 资助金额:
$ 138.08万 - 项目类别:
Project Grants
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
7537247 - 财政年份:2007
- 资助金额:
$ 138.08万 - 项目类别:
INTERACTIONS OF ACTIVINS AND BMP WITH THEIR RECEPTORS
激活素和 BMP 与其受体的相互作用
- 批准号:
6849106 - 财政年份:2003
- 资助金额:
$ 138.08万 - 项目类别:
ROLE OF ACTIVINS IN BRANCHING MORPHOGENESIS OF THE PROSTATE AND OTHER ORGANS
激活素在前列腺和其他器官分支形态发生中的作用
- 批准号:
nhmrc : 7191 - 财政年份:2001
- 资助金额:
$ 138.08万 - 项目类别:
Early Career Fellowships
Biology of activins in fetoplacental hypoxia
胎儿胎盘缺氧中激活素的生物学
- 批准号:
nhmrc : 143769 - 财政年份:2001
- 资助金额:
$ 138.08万 - 项目类别:
NHMRC Postgraduate Scholarships
Roles of inhibins, activins, and follistation in reproductive systems.
抑制素、激活素和卵泡在生殖系统中的作用。
- 批准号:
10460135 - 财政年份:1998
- 资助金额:
$ 138.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6125677 - 财政年份:1994
- 资助金额:
$ 138.08万 - 项目类别:
FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT
发育过程中激活素的功能分析
- 批准号:
6476789 - 财政年份:1994
- 资助金额:
$ 138.08万 - 项目类别: